Rationally designed peptides for controlled release of nerve growth factor from fibrin matrices
Open Access
- 6 September 2006
- journal article
- research article
- Published by Wiley in Journal of Biomedical Materials Research Part A
- Vol. 80A (1) , 13-23
- https://doi.org/10.1002/jbm.a.30844
Abstract
The purpose of this research was to identify peptide sequences with varying affinity for nerve growth factor (NGF) and use them in the rational design of affinity‐based drug delivery systems. A phage display library (12 amino acid random peptide sequence) was screened against NGF‐conjugated chromatography resin three times and fractions containing phage of varying affinity were eluted by decreasing the pH of the eluent. These phages were isolated, amplified; then their DNA was purified and sequenced to determine the identity of the random peptide domain. Consensus peptides based on these sequences were synthesized and screened for their ability to bind NGF and release it at different rates from fibrin matrices. The ability of fibrin matrices containing these peptides and NGF to deliver to biologically active NGF was tested using a chick dorsal root ganglia model. A mathematical model was developed to further understand how the affinity of a peptide can modulate release of NGF and to aid in design optimization for the delivery system. The peptides identified in this study were determined to have varying affinities for NGF suggesting that this approach can serve as a model for tailoring the affinity of a drug delivery system for a target protein drug. © 2006 Wiley Periodicals, Inc. J Biomed Mater Res, 2007Keywords
This publication has 20 references indexed in Scilit:
- Discovery of a sulfated tetrapeptide that binds to vascular endothelial growth factorActa Biomaterialia, 2005
- Neurotrophin releasing single and multiple lumen nerve conduitsJournal of Controlled Release, 2005
- Controlled release of neurotrophin-3 from fibrin gels for spinal cord injuryJournal of Controlled Release, 2004
- Controlled and modulated release of basic fibroblast growth factorPublished by Elsevier ,2003
- Intracerebral Implantation of NGF-Releasing Biodegradable Microspheres Protects Striatum against Excitotoxic DamageExperimental Neurology, 2000
- A Recombinant Human TGF-β1 Fusion Protein with Collagen-Binding Domain Promotes Migration, Growth, and Differentiation of Bone Marrow Mesenchymal CellsExperimental Cell Research, 1999
- Cross-Linking Exogenous Bifunctional Peptides into Fibrin Gels with Factor XIIIaBioconjugate Chemistry, 1998
- Nerve growth factor enhances regeneration through silicone chambersExperimental Neurology, 1989
- Factor XIII‐mediated cross‐linking of NH2‐terminal peptide of α2‐plasmin inhibitor to fibrinFEBS Letters, 1983
- The release of Bβ 1–42 from fibrinogen and fibrin by plasminThrombosis Research, 1983